Efficient Power Conversion (EPC) has announced the EPC91202 evaluation board, a complete three-phase BLDC motor drive ...

V GaN-based inverter reference design delivering 50 ARMS phase current, integrated sensing, and PWM operation up to ...

Integrated GaN power stage with onboard control, sensing, and communication, delivering up to 20 ARMS in a 32 mm ...

Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Collins Aerospace has begun initial tests of the integrated electric elements - including a pair of 1MW-class motors - that ...

Phase 3 FORTIFY interim analysis results presented in a late-breaking oral presentation at MDA highlight the broad and consistent efficacy of BBP-418 across key clinical endpoints and prespecified ...

After a phase of uneven demand, the domestic passenger vehicle business is seeing improving utilisation supported by new ...

Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...

From March 1st, 2026, the new vehicle emissions testing procedure will require inspectors to "press the accelerator to full ...

Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A ...

Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing ...

Genethon, a pioneer and leader in gene therapy for rare diseases, unveiled results at the MDA Conference in Orlando confirming the long-term efficacy of its GNT0004 gene therapy in Duchenne muscular ...